Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who live in British Columbia, Canada and have an active provincial medical services plan (MSP)
- People between 19 and 70 years of age
- People who have a chronic, non-progressive spinal cord injury with complete motor paralysis at or above the T6 level of the spine, OR people diagnosed with Multiple System Atrophy (parkinsonian type) — a condition affecting the nervous system (confirm with trial site)
- People who had their spinal cord injury or diagnosis more than 1 year ago, and who have had at least 6 months since any spinal surgery
- People with a spinal cord injury who meet a specific injury severity classification (AIS A or B), or people with Multiple System Atrophy who experience a significant drop in blood pressure when standing up
- People who are able and willing to attend all clinic visits and follow all study procedures
- People who can understand and communicate in English, or who have access to an appropriate interpreter as assessed by the study team
- People who do not have painful muscle or joint problems, unhealed broken bones, open pressure sores, or active infections that could interfere with testing
- People whose spinal cord injury-related health issues (such as muscle stiffness) are being stably managed
- Women who could become pregnant must not be currently pregnant, breastfeeding, or planning to become pregnant, and must have a confirmed negative pregnancy test before the study begins
- Women who could become pregnant must agree to use effective contraception during the trial and for at least 28 days after the study ends (abstinence is accepted)
- Men who are sexually active and whose partners could become pregnant must agree to use effective contraception during the trial and for at least 28 days after the study ends
- People who are willing to provide informed consent to participate
Who may not be able to join:
- People who depend on a ventilator (breathing machine) to breathe
- People with significant, unmanaged depression (based on a standard questionnaire score above 15) or ongoing substance misuse
- People taking any medication or receiving any treatment that the study doctor believes makes participation unsuitable for that person
- People who have an intrathecal baclofen pump (a device implanted in the spine to deliver muscle relaxant medication)
- People who have heart, lung, bladder, or kidney disease that is unrelated to their spinal cord injury, or who have kidney swelling (hydronephrosis) or blocking kidney stones
- People with a serious current health issue that the study doctor believes would negatively affect their ability to participate — examples include active urinary tract infections, a bone condition called heterotopic ossification, recent changes to certain antidepressant medications, severe muscle pain, pressure sores, or unstable diabetes
- People who have any metal implants (other than dental implants) in the skull, or who have a pacemaker, stimulator, or medication pump in the trunk of the body
- People who take more than 40mg of Baclofen (a muscle relaxant medication) per day
- People with severe anaemia or low blood volume, as shown by a blood test taken in the last six months
- People who are a member of the research team running this trial, or an immediate family member of someone on the team
- People who have previously had electrode implant surgery
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Michael J Berger, MD, FRCPC, The University of British Columbia
Phone: 604-675-8856
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Systolic blood pressure (SBP) changes in millimeters of mercury (mmHg) during TSCS; Blood pressure (BP) changes in millimeters of mercury (mmHg) in 24-hrs
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.